Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Clinical Oncology

• Publication date

  2017-01-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2016.71.0012PMID 28135145PMCID PMC5455355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Population Frequency of Germline BRCA1/2 Mutations.

  2016influential reference
• Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

  2016cited by this paper
• Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.

  2016cited by this paper
• Counselling framework for moderate-penetrance cancer-susceptibility mutations

  2016cited by this paper
• Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

  2016cited by this paper
• Reply to percentage of colorectal cancer diagnoses in adults aged younger than 50 years

  2016cited by this paper
• Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.

  2016cited by this paper
• Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.

  2015cited by this paper
• Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.

  2015cited by this paper
• Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.

  2015cited by this paper
• Somatic c.34G>T KRAS mutation: a new prescreening test for MUTYH-associated polyposis?

  2015cited by this paper
• BRCA2 gene: a candidate for clinical testing in familial colorectal cancer type X

  2015influential reference
• Gene-panel sequencing and the prediction of breast-cancer risk.

  2015cited by this paper
• PD-1 blockade in tumors with mismatch repair deficiency.

  2015cited by this paper
• ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

  2015influential reference
• PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

  2015cited by this paper
• Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis.

  2015cited by this paper
• DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

  2015cited by this paper
• Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative.

  2014cited by this paper
• Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer.

  2014cited by this paper
• Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.

  2014cited by this paper
• Prevalence and Characteristics of MUTYH-Associated Polyposis in Patients with Multiple Adenomatous and Serrated Polyps

  2014influential reference
• Breast-cancer risk in families with mutations in PALB2.

  2014cited by this paper
• Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer.

  2014cited by this paper
• Breast-cancer risk in families with mutations in PALB2.

  2014cited by this paper
• Li-Fraumeni syndrome

  2013cited by this paper
• Population-based molecular screening for Lynch syndrome: implications for personalized medicine.

  2013cited by this paper
• Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study

  2013influential reference
• The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.

  2013cited by this paper
• Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.

  2012cited by this paper
• Identification of Lynch syndrome among patients with colorectal cancer.

  2012cited by this paper
• Li-fraumeni syndrome.

  2011cited by this paper
• American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.

  2010cited by this paper
• The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease

  2010cited by this paper
• BRCA1 mutations and colorectal cancer in Poland

  2010influential reference
• Genetic/familial high-risk assessment: breast and ovarian.

  2010influential reference
• Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study.

  2009cited by this paper
• Clinical implications of the colorectal cancer risk associated with MUTYH mutation.

  2009cited by this paper
• Feasibility of screening for Lynch syndrome among patients with colorectal cancer.

  2008cited by this paper
• Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations

  2007influential reference
• Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: Public health implications

  2005influential reference
• Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

  2005cited by this paper
• Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer.

  2004cited by this paper
• Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.

  2004cited by this paper
• BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer.

  2004cited by this paper
• Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis.

  2003cited by this paper
• Geographical variation in the penetrance of CDKN2A mutations for melanoma.

  2002cited by this paper
• T E C H N I C a L a D V a N C E Open Access

  year unknowncited by this paper

• Hsa_circ_0002103 promotes progression of colorectal cancer via miR-193a-3p/CCND1 axis.

  2026cites this paper
• The significance of immunogenic cell death related prognostic gene markers in colorectal cancer prognosis and antitumor immunity

  2026cites this paper
• Integration of multi-omics data uncovers novel germline susceptibility candidates in early-onset colorectal cancer.

  2026cites this paper
• Research progress in diagnosis and treatment of pancreatic cancer with mismatch repair and microsatellite instability.

  2026cites this paper
• Prognostic value and experimental validation of atherosclerosis-derived pathogenic genes in colorectal cancer

  2026cites this paper
• The Incidental Diagnosis: Familial Adenomatous Polyposis Unmasked by CT in a Young Male Presenting with Chronic, Refractory Anemia

  2026cites this paper
• Colorectal cancer in Lynch syndrome families: consequences of gene germline mutations and the gut microbiota

  2025cites this paper
• Feasibility and impact of Lynch syndrome genetic testing in newly diagnosed colorectal cancer patients: a multicenter observational study in Greece.

  2025cites this paper
• Retrospective Study of Genetic Testing Results Reveals Pathogenic Variants Beyond BRCA1/2 in Hereditary Breast and Ovarian Cancer Cases in New Brunswick: Implications for Future Care

  2025cites this paper
• Whole-Exome Sequencing-Identified Germline Variants Underlie High Familial Risk and Early-Onset Colorectal Cancer in Taiwan.

  2025cites this paper
• Clinical and genomic features of Lynch syndrome differ by tumor site and disease spectrum

  2025cites this paper
• Cost-Effectiveness of Lynch Syndrome Identification Strategies in Individuals with Colorectal Cancer and the Impact on At-Risk Relatives.

  2025cites this paper
• Research Progress of DNA Methylation Markers for Endometrial Carcinoma Diagnosis

  2025cites this paper
• Mutational and co-mutational landscape of early onset colorectal cancer

  2025cites this paper
• PARP Inhibition in Colorectal Cancer—A Comparison of Potential Predictive Biomarkers for Therapy

  2025influential citation
• MGPT in Advanced Adenomas: Predictive, Actionable, or Premature?

  2025cites this paper
• Hereditary Colorectal Cancer: Clinical Implications of Genomic Medicine and Precision Oncology

  2025influential citation
• Reply to Wang and Chen.

  2025cites this paper
• Systematic characterization of full-length RNA isoforms in human colorectal cancer at single-cell resolution

  2025cites this paper
• A rare subtype of lynch syndrome familial with co-mutation of EpCAM c.344T>C, MSH2 c.2744A>G, PMS2 c.1408C>T and APC c.5465T>A, case report and literature review

  2025cites this paper
• Early-Onset Colorectal Cancer: From Genetic Discovery to Clinical Innovation.

  2025cites this paper
• Early-Onset Gastrointestinal Cancers: A Review.

  2025cites this paper
• Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer

  2025cites this paper
• Germline variant spectrum of hereditary cancer susceptibility genes in a Chinese cohort

  2025cites this paper
• Raising the age for starting colonoscopy to 35 years for individuals with path_MSH6 carriers may lead to missed opportunities for detecting advanced neoplasia in a notable percentage of carriers.

  2025cites this paper
• Advancements of nanoscale drug formulations for combination treatment of colorectal cancer.

  2025cites this paper
• Association of Fusobacterium nucleatum with colorectal cancer molecular subtypes and its outcome: a systematic review

  2025cites this paper
• Polyphenol Intake in Elderly Patients: A Novel Approach to Counteract Colorectal Cancer Risk?

  2025cites this paper
• Molecular Detection of (I1307k) Mutation in the Adenomatous Polyposis Coli Among Sudanese Colorectal Cancer Patients, Sudan

  2025cites this paper
• Lynch Syndrome—Impact of the Type of Deficient Mismatch Repair Gene Mutation on Diagnosis, Clinical Presentation, Surveillance and Therapeutic Approaches

  2025cites this paper
• LASSO-derived nomogram prediction model for lymph node metastasis in colorectal cancer: a retrospective analysis

  2025cites this paper
• Downregulation of the Tumor Suppressor P53 Gene associated with the Progression of Clinical Staging and the Incidence of Distant Metastasis in Indonesian Colorectal Cancer

  2025influential citation
• The Clinical Outcomes Among Patients Under 60 Years Old with Lynch Syndrome: Variations Based on Different Mutation Patterns

  2025influential citation
• Yield of Multigene Panel Germline Genetic Testing Among those with Advanced Colorectal Adenomas.

  2025cites this paper
• From gaps to compliance: a 12-year retrospective cohort study of trends in mismatch repair protein testing and Lynch syndrome identification in colorectal cancer in Central Switzerland.

  2025cites this paper
• The Process of Cancer Prevention Behaviors in Individuals at High Risk of Hereditary Cancer: A Grounded Theory Study

  2025cites this paper
• Consideration for Multigene Panel Testing Outside of Cancer-Specific Genetic Testing.

  2025cites this paper
• Dysfunctional mismatch repair in patients with early triple-negative breast cancer

  2025influential citation
• Integrating next-generation sequencing and artificial intelligence for the identification and validation of pathogenic variants in colorectal cancer

  2025cites this paper
• Pathogenic germline variants in mismatch repair genes in patients with microsatellite instability-high gastric cancer.

  2025cites this paper
• Genetic variants linked to type 2 diabetes in CDKN1B and TCF7L2 influence survival outcomes in metastatic colorectal cancer

  2025cites this paper
• Pragmatic approach to implementation of universal MSI testing for new cases of colorectal cancer

  2025cites this paper
• Contribution of BARD1 gene to male breast cancer- report of a family with different types of cancer.

  2025cites this paper
• In Our Scope of Practice: Genetic Risk Assessment and Testing for GI Cancers and Polyposis in Gastroenterology.

  2025cites this paper
• Construction of a target-stimulated nanoparticle-assembly homogeneous sensing platform for multiplexed DNA methylation assay

  2025cites this paper
• Residual/recurrent lesions after cold-knife conization for high-grade cervical intraepithelial neoplasia: risk factor analysis and clinical management recommendations

  2025cites this paper
• Genomic Landscapes of Early-Onset Versus Average-Onset Colorectal Cancer Populations

  2025cites this paper
• HSF1 promotes malignant phenotype in colorectal cancer via super-enhancer-driven lncRNA EXOSC10-AS1 and targeting HSF1 confers sensitivity to poly (ADP-ribose) polymerase inhibitor Niraparib.

  2025cites this paper
• Germline variants in patients from the Iranian hereditary colorectal cancer registry

  2025cites this paper
• Genotype-phenotype correlations in PMS2-associated constitutional mismatch repair deficiency: a systematic literature review

  2025cites this paper
• Toward Earlier Detection: Revisiting Colorectal Cancer Screening Age in the U.S. and Europe

  2025cites this paper
• Targeted Resequencing of DNA Repair Genes in Familial Colorectal Cancer: Insights from a Custom 56-Gene Panel

  2025cites this paper
• Decoding the genetic and environmental forces in propelling the surge of early-onset colorectal cancer

  2025cites this paper
• Analysis of germline-somatic mutational connections in colorectal cancer reveals differential tumorigenic patterns and a novel predictive marker for germline mutation carriers.

  2025cites this paper
• Germinal pathogenic CHEK2, novel APC and somatic JAK2V617F variants in a young patient with colorectal cancer, atypical leukemia, cerebral tumour and aggressive course

  2025cites this paper
• Immunotherapy With Pembrolizumab for Resectable dMMR/MSI-H Stage III Colon Cancer: A Case of Personalized, Precision Surgery-Sparing Immunotherapy

  2025cites this paper
• Syndrome de Lynch

  2024cites this paper
• Precision Medicine for Metastatic Colorectal Cancer: Where Do We Stand?

  2024cites this paper
• Adrenocortical tumors and hereditary syndromes

  2024cites this paper
• Genetic landscape of Romanian PPGLs

  2024cites this paper
• Carrier Frequency and Incidence of MUTYH-Associated Polyposis Based on Database Analysis in East Asians and Koreans

  2024cites this paper
• Uptake of Aspirin Chemoprevention in Patients With Lynch Syndrome

  2024cites this paper
• Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology.

  2024cites this paper
• Large-scale application of ClinGen-InSiGHT APC-specific ACMG/AMP variant classification criteria leads to substantial reduction in VUS

  2024cites this paper
• A watch-and-wait approach for metachronous multiple colon cancer following neoadjuvant immunotherapy: a case report

  2024cites this paper
• Targeting PARP-1 and DNA Damage Response Defects in Colorectal Cancer Chemotherapy with Established and Novel PARP Inhibitors

  2024cites this paper
• Poor compliance with germline testing recommendations in colorectal cancer patients undergoing molecular residual disease testing

  2024cites this paper
• Rare HNRNPH1::ERG rearrangement in a case of de novo pediatric AML and review of cases

  2024cites this paper
• Prevalence and spectrum of germline pathogenic variants in cancer susceptibility genes among mexican patients with exocrine pancreatic cancer.

  2024cites this paper
• Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models

  2024cites this paper
• Diagnostic Performance of Faecal Immunochemical Testing (FIT) in Patients with Lynch Syndrome Scheduled for Colonoscopic Surveillance

  2024cites this paper
• HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients

  2024cites this paper
• Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms

  2024cites this paper
• In Silico Deciphering of the Potential Impact of Variants of Uncertain Significance in Hereditary Colorectal Cancer Syndromes

  2024cites this paper
• Genetic Testing in Colorectal Cancer: Towards a Better Understanding and Utilization by Clinicians.

  2024cites this paper
• Synergistic Mechanisms of Selected Polyphenols in Overcoming Chemoresistance and Enhancing Chemosensitivity in Colorectal Cancer

  2024cites this paper
• Colonoscopy and Upper Endoscopy Surveillance in Lynch Syndrome: A Longitudinal Study From a Large Tertiary Healthcare System

  2024cites this paper
• Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers

  2024cites this paper
• Systematic large-scale application of ClinGen InSiGHT APC-specific ACMG/AMP variant classification criteria substantially alleviates the burden of variants of uncertain significance in ClinVar and LOVD databases

  2024cites this paper
• A Comprehensive Pan-Cancer Analysis Reveals Cyclin-Dependent Kinase Inhibitor 2A Gene as a Potential Diagnostic and Prognostic Biomarker in Colon Adenocarcinoma

  2024cites this paper
• Liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon Cancer.

  2024cites this paper
• Use of multi-gene panels in patients at high risk of hereditary digestive cancer: Position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium

  2024cites this paper
• Determinants of early-onset colorectal cancer: a multicenter case-control study in Iran

  2024cites this paper
• Mutations in Mismatch Repair Genes and Microsatellite Instability Status in Pancreatic Cancer

  2024cites this paper
• Low Rates of Colorectal Cancer Screening in First-Degree Relatives of Our Patients: Are We Failing Them?

  2024cites this paper
• BARD1 deletion in a patient with suspected hereditary colorectal cancer

  2024cites this paper
• Seed and Soil: Consensus Molecular Subgroups (CMS) and Tumor Microenvironment Features Between Primary Lesions and Metastases of Different Organ Sites in Colorectal Cancer

  2024cites this paper
• Lynch Syndrome: From Multidisciplinary Management to Precision Prevention

  2024cites this paper
• Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes

  2024influential citation
• A risk-prediction score about colorectal lesions based on the Chinese population of high-risk participants aged 50-65 years.

  2024cites this paper
• Founder pathogenic variants in colorectal neoplasia susceptibility genes in Ashkenazi Jews undergoing colonoscopy

  2024cites this paper
• Prognostic impact of primary tumour location after curative resection in Stage I-III colorectal cancer: a single-centre retrospective study.

  2024cites this paper
• Predictors for dMMR colorectal cancer in patients with serrated lesions and polyps - A register-based cohort study.

  2024cites this paper
• Biomarker Profile of Colorectal Cancer: Current Findings and Future Perspective

  2024influential citation
• Pharmacodynamic components and mechanisms of ginger (Zingiber officinale) in the prevention and treatment of colorectal cancer.

  2024cites this paper
• GI Polyps and Polyposis in Individuals Harboring Germline CHEK2 Mutations

  2024cites this paper
• Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice

  2024influential citation
• Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.

  2024cites this paper
• An immunosuppressive subtype of senescent tumor cells predicted worse immunotherapy response in lung adenocarcinoma.

  2023cites this paper
• Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia

  2023cites this paper